SCHEMBL12974095

SCHEMBL12974095

CC(C)c1cc(I)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 3/20 0.46
▸ GABRB1 P18505 3/20 0.46
▸ GABRB2 P47870 2/20 0.46
▸ LMNA P02545 5/20 0.36
▸ IDO1 P14902 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ PNMT P11086 1/20 0.31
▸ SLC6A2 P23975 2/20 0.30
▸ HTR2B P41595 2/20 0.30
▸ TRPA1 O75762 1/20 0.30
▸ CHRM1 P11229 1/20 0.30
▸ ADRA1A P35348 1/20 0.30
▸ GCGR P47871 1/20 0.30
▸ CA1 P00915 2/20 0.30
▸ CA2 P00918 2/20 0.30
▸ FAAH O00519 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27822371 0.83 GABRA1 (0.34) GABRA1GABRB1GABRB2LMNAIDO1
SCHEMBL4190146 0.83 PDE2A (0.42) GABRA1GABRB1GABRB2LMNAIDO1
SCHEMBL12806675 0.82 LMNA (0.42) GABRA1GABRB1GABRB2LMNAIDO1
SCHEMBL28773626 0.79 IDO1 (0.34) IDO1CYP1A2
SCHEMBL12197671 0.78 GABRA1 (0.52) GABRA1GABRB1GABRB2LMNASLC6A2
SCHEMBL22097553 0.77 IDO1 (0.33) GABRA1GABRB1GABRB2IDO1SLC6A2
SCHEMBL28773732 0.77 IDO1 (0.33) IDO1
SCHEMBL423288 0.76 TP53 (0.50) GABRA1GABRB1LMNATP53HTT
SCHEMBL13818840 0.76 GABRA1 (0.50) GABRA1GABRB1GABRB2LMNASLC6A2
SCHEMBL7644307 0.74 LMNA (0.41) GABRA1GABRB1GABRB2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962244-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2015-02-24 — — US disclosed
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2013-08-22 — — US disclosed
WO-2010151797-A2 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2010-12-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 GABRA1 1857/4885GABRB1 1729/4885GABRB2 2445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback